Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asteroid 3: vilaprisan for heavy menstrual bleeding associated with uterine fibroids
MOH_2018-03-19_001979Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Fibromyoma (LM) comparing Vilaprisan with Placebo (2 arms). Started Dec 2017; status: completed.
02
Drugs
vilaprisan
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on MOH_2018-03-19_001979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-03-19_001979.